Skip to main content
. 2022 Feb 28;8:91. doi: 10.1038/s41420-022-00883-z

Fig. 2. Co-expression of EIF4EBP1 and EIF4EBP1 promoter binding transcription factor genes in glioblastoma tissue samples.

Fig. 2

AG Expression levels of EIF4EBP1 mRNA in glioblastoma patient samples plotted against the mRNA expression levels of (A) MYBL2, (B) FOXM1, (C) ETS1, (D) HIF-1A, (E) JUN, (F) E2F1 or (G) E2F6 in the REMBRANDT cohort (n = 228 patients) [26]. Co-expression levels were quantified by calculating the Pearson correlation coefficient. H ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (−1500 to +1000; hg38; Chr8: 38,029,034–38,031,534) from ChIP-sequencing data for histone H3K27 acetylation (H3K27ac) and H3K4 trimethylation (H3K4me3), ETS1, FOXM1, JUN, E2F1, and E2F6 (Encode consortium, Encyclopedia of DNA Elements at UCSC; [41, 42]), HIF-1A (accession code GSE39089; name GSM955978; run SRR518265 [43]) and MYBL2 (accession code GSE119972; name GSM3389599 [44]).